Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade

Cardinal Health (CAH) reached $246.45 at the closing of the latest trading day, reflecting a -2.02% change compared to its last close.

Zacks Investment Research • Oct 27, 2026

The Dividend Aristocrats Ranked By Quality Scores (October 2026)

I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.

Seeking Alpha • Oct 23, 2026

Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.

Zacks Investment Research • Oct 20, 2026

Big tech is wobbling. Goldman Sachs says it's time to buy these 23 unloved stocks instead.

Goldman Sachs says consumer-facing laggard stocks are the best way forward as earnings growth is set to slow next year and big tech stocks struggle.

Market Watch • Oct 19, 2026

3 Low-Beta Defensive Stocks to Buy as Inflation Continues to Surge

As inflation surges on rising energy costs, CAH, UNH and CORT stand out as low-beta healthcare stocks with strong expected earnings growth and defensive appeal.

Zacks Investment Research • Oct 15, 2026

Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.

Zacks Investment Research • Oct 13, 2026

Should Value Investors Buy Cardinal Health (CAH) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Oct 13, 2026

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Oct 13, 2026

Reasons to Retain Cardinal Health Stock in Your Portfolio for Now

CAH enters fiscal 2027 with Pharma profit growth, emerging growth engines and efficiency gains offsetting revenue headwinds.

Zacks Investment Research • Oct 6, 2026

Cardinal Health (CAH) Outperforms Broader Market: What You Need to Know

Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.

Zacks Investment Research • Oct 5, 2026